中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2014年
27期
2110-2114
,共5页
高志伟%刘玲%刘松桥%谢剑锋%潘红%邱海波%杨毅
高誌偉%劉玲%劉鬆橋%謝劍鋒%潘紅%邱海波%楊毅
고지위%류령%류송교%사검봉%반홍%구해파%양의
高频通气%呼吸窘迫综合征,成人型%死亡率%综合分析
高頻通氣%呼吸窘迫綜閤徵,成人型%死亡率%綜閤分析
고빈통기%호흡군박종합정,성인형%사망솔%종합분석
High-frequency ventilation%Respiratory distress syndrome,adult%Mortality%Meta-analysis
目的 评估高频振荡通气(HFOV)对急性呼吸窘迫综合征(ARDS)患者预后的影响.方法 联机检索MEDLINE、Embase、Web of Science和CNKI等中英文数据库,收集1970年1月至2013年5月HFOV治疗成人ARDS的英文和中文临床随机对照研究(RCT)文献,按纳入与排除标准选择文献,采用RevMan 5.0软件对数据进行荟萃分析.结果 共纳入6篇RCT文献,入选1 634例ARDS患者,HFOV治疗组827例,常规机械通气治疗(CMV)对照组807例.将HFOV对成人ARDS患者住院或30 d病死率进行荟萃分析:与CMV相比,HFOV不能降低成人ARDS患者住院或30 d病死率,OR值=0.95 [95%可信区间(CI)0.62~1.46,P=0.83].结论 与CMV相比,HFOV不能改善成人ARDS患者的预后.
目的 評估高頻振盪通氣(HFOV)對急性呼吸窘迫綜閤徵(ARDS)患者預後的影響.方法 聯機檢索MEDLINE、Embase、Web of Science和CNKI等中英文數據庫,收集1970年1月至2013年5月HFOV治療成人ARDS的英文和中文臨床隨機對照研究(RCT)文獻,按納入與排除標準選擇文獻,採用RevMan 5.0軟件對數據進行薈萃分析.結果 共納入6篇RCT文獻,入選1 634例ARDS患者,HFOV治療組827例,常規機械通氣治療(CMV)對照組807例.將HFOV對成人ARDS患者住院或30 d病死率進行薈萃分析:與CMV相比,HFOV不能降低成人ARDS患者住院或30 d病死率,OR值=0.95 [95%可信區間(CI)0.62~1.46,P=0.83].結論 與CMV相比,HFOV不能改善成人ARDS患者的預後.
목적 평고고빈진탕통기(HFOV)대급성호흡군박종합정(ARDS)환자예후적영향.방법 련궤검색MEDLINE、Embase、Web of Science화CNKI등중영문수거고,수집1970년1월지2013년5월HFOV치료성인ARDS적영문화중문림상수궤대조연구(RCT)문헌,안납입여배제표준선택문헌,채용RevMan 5.0연건대수거진행회췌분석.결과 공납입6편RCT문헌,입선1 634례ARDS환자,HFOV치료조827례,상규궤계통기치료(CMV)대조조807례.장HFOV대성인ARDS환자주원혹30 d병사솔진행회췌분석:여CMV상비,HFOV불능강저성인ARDS환자주원혹30 d병사솔,OR치=0.95 [95%가신구간(CI)0.62~1.46,P=0.83].결론 여CMV상비,HFOV불능개선성인ARDS환자적예후.
Objective To evaluate the effects of high-frequency oscillatory ventilation (HFOV) on mortality in patients with acute respiratory distress syndrome (ARDS).Methods Randomized controlled trials (RCTs) of HFOV as compared with conventional mechanical ventilation (CMV) in adult patients with ARDS from January 1970 to May 2013 were recruited.The data were analyzed with the methods recommended by the Cochrane Collaboration's software RevMan 5.0.Results Six RCTs using HFOV in adult patients with ARDS were collected for analysis.Among 1 634 eligible ARDS patients,827 of them were enrolled into HFOV group and the reminder into CMV group.Meta-analysis revealed HFOV did not significantly decrease the hospitalization or 30-day mortality of adult ARDS patients (OR =0.95,95% CI 0.62-1.46,P =0.83).Conclusion Compared with CMV,HFOV dose not improve prognosis in adult patients with ARDS.Thus more high-quality RCTs with larger samples are warranted.